Anna Lena Lopez Selected Research

Cholera Vaccines

1/2018	Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.
1/2018	Cholera prevention and control in Asian countries.
1/2016	The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.
3/2015	Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.
9/2014	Killed oral cholera vaccines: history, development and implementation challenges.
2/2014	Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
1/2011	Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.
6/2008	A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.
3/2008	Cholera vaccines for the developing world.
1/2008	Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Lena Lopez Research Topics

Disease

23	Cholera 01/2020 - 01/2007
5	Dengue (Dengue Fever) 06/2021 - 10/2017
3	Infections 06/2021 - 01/2013
3	Diarrhea 01/2019 - 01/2018
2	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 04/2017 - 01/2016
2	Rubella (German Measles) 04/2017 - 01/2016
1	Tuberculosis (Tuberculoses) 02/2019
1	Pneumonia (Pneumonitis) 01/2011
1	Typhoid Fever (Typhoid) 10/2010

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 01/2021 - 01/2007
11	Cholera Vaccines FDA Link 01/2018 - 01/2007
4	Immunoglobulin G (IgG)IBA 06/2021 - 01/2016
3	Dengue VaccinesIBA 06/2021 - 10/2017
1	Immunoglobulins (Immunoglobulin)IBA 06/2021
1	AntibodiesIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Bacterial VaccinesIBA 01/2012
1	Drinking WaterIBA 01/2011
1	Cholera ToxinIBA 05/2009
1	ElementsIBA 05/2009